Absence of chemokine (C-X-C Motif) ligand 10 diminishes perfusion recovery after local arterial occlusion in mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 3, 2014, Pages 594-602

  Van Den Borne, Pleunie ^a   Haverslag, René T ^a   Brandt, Maarten M ^b   Cheng, Caroline ^a,b   Duckers, Henricus J ^a   Quax, Paul H A ^c   Hoefer, Imo E ^a,d   Pasterkamp, Gerard ^a,d   De Kleijn, Dominique P V ^a,d,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^e NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Cell movement; Chemokine CXCL10; Inflammation; interferon inducible protein of 10 kDa; Myocytes, smooth muscle

Indexed keywords

CELL MOVEMENT; CHEMOKINE CXCL10; INFLAMMATION; INTERFERON-Γ-INDUCIBLE PROTEIN OF 10 KDA; MYOCYTES, SMOOTH MUSCLE;

ANIMALS; AORTA; BONE MARROW; CELLS, CULTURED; CHEMOKINE CXCL10; COLLATERAL CIRCULATION; FEMALE; FEMORAL ARTERY; HINDLIMB; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; ISCHEMIA; LASER-DOPPLER FLOWMETRY; LIGATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; RADIATION CHIMERA; RECOMBINANT PROTEINS; REPERFUSION INJURY; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84894539883     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.303050     Document Type: Article

References (27)

1. Schaper W. Collateral circulation: Past and present. Basic Res Cardiol. 2009;104:5-21
2. de Groot D, Hoefer IE, Grundmann S, Schoneveld A, Haverslag RT, van Keulen JK, Bot PT, Timmers L, Piek JJ, Pasterkamp G, de Kleijn DP. Arteriogenesis requires toll-like receptor 2 and 4 expression in bone-marrow derived cells. J Mol Cell Cardiol. 2011;50:25-32
3. de Groot D, Haverslag RT, Pasterkamp G, de Kleijn DP, Hoefer IE. Targeted deletion of the inhibitory NF-kappaB p50 subunit in bone marrow-derived cells improves collateral growth after arterial occlusion. Cardiovasc Res. 2010;88:179-185
4. Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Wiesnet M, Busse R, Schaper J, Schaper W. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch. 2000;436:257-270
5. Cai W, Schaper W. Mechanisms of arteriogenesis. Acta Biochim Biophys Sin (Shanghai). 2008;40:681-692
6. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395
7. Wolf C, Cai WJ, Vosschulte R, Koltai S, Mousavipour D, Scholz D, Afsah-Hedjri A, Schaper W, Schaper J. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol. 1998;30:2291-2305
8. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, Eberli FR, Meier B. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: A randomized, double-blind, placebo-controlled study. Circulation. 2001;104:2012-2017
9. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, Schaper W. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol. 2002;283:H2411-H2419
10. Herold J, Pipp F, Fernandez B, Xing Z, Heil M, Tillmanns H, Braun-Dullaeus RC. Transplantation of monocytes: A novel strategy for in vivo augmentation of collateral vessel growth. Hum Gene Ther. 2004;15:1-12
11. Lee CW, Stabile E, Kinnaird T, Shou M, Devaney JM, Epstein SE, Burnett MS. Temporal patterns of gene expression after acute hindlimb ischemia in mice: Insights into the genomic program for collateral vessel development. J Am Coll Cardiol. 2004;43:474-482
12. Taub DD, Longo DL, Murphy WJ. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood. 1996;87:1423-1431
13. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 2002;168:3195-3204
14. Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation. 2006;113:2301-2312
15. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996;184:963-969
16. Luster AD, Ravetch J V. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J Exp Med. 1987;166:1084-1097
17. Wang X, Yue TL, Ohlstein EH, Sung CP, Feuerstein GZ. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem. 1996;271:24286-24293
18. Zuojun H, Lingyu H, Wei H, Henghui Y, Chonggang Z, Jingsong W, Mian W, Yong L, Shenming W. Interference of IP-10 expression inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in carotid artery: A new insight in the prevention of restenosis. Cell Biochem Biophys. 2012;62:125-135
19. Waeckel L, Mallat Z, Potteaux S, Combadière C, Clergue M, Duriez M, Bao L, Gerard C, Rollins BJ, Tedgui A, Levy BI, Silvestre JS. Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3. Circ Res. 2005;96:576-582
20. Haverslag R, de Groot D, van den Borne P, Pasterkamp G, Hoefer IE. Arterial occlusion induces systemic changes in leucocyte composition. Eur J Clin Invest. 2011;41:943-950
21. Bujak M, Dobaczewski M, Gonzalez-Quesada C, Xia Y, Leucker T, Zymek P, Veeranna V, Tager AM, Luster AD, Frangogiannis NG. Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res. 2009;105:973-983
22. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993;177:1809-1814
23. Wallace AE, Cartwright JE, Begum R, Laing K, Thilaganathan B, Whitley GS. Trophoblast-induced changes in C-x-C motif chemokine 10 expression contribute to vascular smooth muscle cell dedifferentiation during spiral artery remodeling. Arterioscler Thromb Vasc Biol. 2013;33:e93-e101
24. Yates-Binder CC, Rodgers M, Jaynes J, Wells A, Bodnar RJ, Turner T. An IP-10 (CXCL10)-derived peptide inhibits angiogenesis. PLoS One. 2012;7:e40812
25. Romagnani P, Crescioli C. CXCL10: A candidate biomarker in transplantation. Clin Chim Acta. 2012;413:1364-1373
26. Billottet C, Quemener C, Bikfalvi A. CXCR3, a double-edged sword in tumor progression and angiogenesis. Biochim Biophys Acta. 2013;1836:287-295
27. Gallo A, Saad A, Ali R, Dardik A, Tellides G, Geirsson A. Circulating interferon-γ-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice. J Thorac Cardiovasc Surg. 2012;143:704-710